Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to -$15.2 million.

  • Ingevity's Change in Receivables rose 4176.25% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 6182.43%. This contributed to the annual value of -$38.2 million for FY2024, which is 1053.86% up from last year.
  • As of Q3 2025, Ingevity's Change in Receivables stood at -$15.2 million, which was up 4176.25% from $27.8 million recorded in Q2 2025.
  • Ingevity's 5-year Change in Receivables high stood at $46.1 million for Q1 2022, and its period low was -$56.3 million during Q4 2022.
  • Its 5-year average for Change in Receivables is $468421.1, with a median of $10.2 million in 2024.
  • Data for Ingevity's Change in Receivables shows a peak YoY increase of 346000.0% (in 2022) and a maximum YoY decrease of 29097.22% (in 2022) over the last 5 years.
  • Over the past 5 years, Ingevity's Change in Receivables (Quarter) stood at -$14.4 million in 2021, then crashed by 290.97% to -$56.3 million in 2022, then skyrocketed by 34.99% to -$36.6 million in 2023, then decreased by 23.5% to -$45.2 million in 2024, then surged by 66.37% to -$15.2 million in 2025.
  • Its Change in Receivables stands at -$15.2 million for Q3 2025, versus $27.8 million for Q2 2025 and $21.3 million for Q1 2025.